J Korean Neurol Assoc.  2017 Aug;35(3):151-154. 10.17340/jkna.2017.35.3.7.

Reversible Cerebral Vasoconstriction Syndrome Presenting with Bilateral Occipital Hemorrhage after the Subcutaneous Injection of Synthetic Gonadotropin Releasing Hormone

Affiliations
  • 1Department of Neurology, Seoul National University College of Medicine, Seoul, Korea. mkhan@snu.ac.kr
  • 2Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 3Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea.

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a heterogeneous group of cerebrovascular disease. The pathophysiology of RCVS is unknown, but a disturbance in cerebral vascular tone is one of hypothesis. Long-term use of Gonadotropin-releasing hormone (GnRH) agonists can induce a pseudomenopausal state in which estrogen production are suppressed. It might lead to reduced arterial relaxation by estrogen withdrawal. We report a case of RCVS after the injection of synthetic analogue of GnRH.

Keyword

Reversible cerebral vasoconstriction syndrome; Intracerebral hemorrhage; Synthetic analogue of gonadotropin releasing hormone

MeSH Terms

Cerebral Hemorrhage
Cerebrovascular Disorders
Estrogens
Gonadotropin-Releasing Hormone*
Gonadotropins*
Hemorrhage*
Injections, Subcutaneous*
Relaxation
Vasoconstriction*
Estrogens
Gonadotropin-Releasing Hormone
Gonadotropins
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr